Bio Simulation Technology - Global Market Outlook (2015-2022)
According to Stratistics MRC, the Bio Simulation Technology Market is estimated at $1.01 billion in 2015 and is projected to reach $2.99 billion by 2022 growing at a CAGR of 16.6% from 2015 to 2022. Reduction in the cost of drug discovery and development and risk of failure of drug molecule are some of the factors driving the market growth. Furthermore, R&D investments in biotechnology and pharmaceutical industries, growth in the biologics and biosimilars markets, increased use of personalized medicines, technological advancements and periodic product upgradation are the key factors vitalizing the market growth. However, lack of standardization, high R&D costs associated with development of biosimulation software and lack of skilled professionals are some of the major restraints hampering the market growth. Industrial bioprocessing, nutraceuticals, agri-food production and biosimulation in the defense will provide opportunities for market growth over the forecast period.
Pharmaceutical and biotechnology companies segment is valued to account largest share across the global market. North America is anticipated to command the largest share and Europe is expected to register the highest growth due to increasing government funding and the large number of pharmaceuticals and biotechnology companies in this region.
Some of the key players in this market include Certara USA Inc., Simulation Plus Inc., Dassault Systèmes SA, Schrödinger Inc., Advanced Chemistry Development Inc., Chemical Computing Group Inc., Entelos Holding Corporation, Genedata Ag, Physiomics PLC, Rhenovia Pharma Ltd., Insilico biosciences, Archimedes, Insilico biotechnology, Accelrys, LeadScope and Compugen.
Application Covered:
Pharmaceutical and biotechnology companies segment is valued to account largest share across the global market. North America is anticipated to command the largest share and Europe is expected to register the highest growth due to increasing government funding and the large number of pharmaceuticals and biotechnology companies in this region.
Some of the key players in this market include Certara USA Inc., Simulation Plus Inc., Dassault Systèmes SA, Schrödinger Inc., Advanced Chemistry Development Inc., Chemical Computing Group Inc., Entelos Holding Corporation, Genedata Ag, Physiomics PLC, Rhenovia Pharma Ltd., Insilico biosciences, Archimedes, Insilico biotechnology, Accelrys, LeadScope and Compugen.
Application Covered:
- Application In Drug Development
- Clinical Trials
- Preclinical Testing
- In Patient Validation
- Application In Drug Discovery
- Target Validation
- Target Identification
- Lead Identification/Discovery
- Lead Optimization
- Software
- Toxicity Prediction Software
- Molecular Modeling and Simulation Software
- Trial Design Software
- PK/PD Modeling and Simulation Software
- Pbpk Modeling and Simulation Software
- Other Software
- Services
- External/Contract Services
- In-House Services
- Regulatory Authorities
- Academic and Government Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Regulatory Guidelines
3.7 Product Analysis
3.8 Application Analysis
3.9 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL BIO SIMULATION TECHNOLOGY MARKET, BY APPLICATION
5.1 Introduction
5.2 Application In Drug Development
5.2.1 Clinical Trials
5.2.1.1 Phase I Clinical Trial
5.2.1.2 Phase Ii Clinical Trial
5.2.1.3 Phase Iii Clinical Trial
5.2.2 Preclinical Testing
5.2.2.1 PK/PD
5.2.2.2 ADME/TOX
5.3 In Patient Validation
5.4 Application In Drug Discovery
5.4.1 Target Validation
5.4.1.1 Molecular Modeling
5.4.2 Target Identification
5.4.2.1 Protein Structure Prediction
5.4.3 Lead Identification/Discovery
5.4.3.1 De Novo Design
5.4.4 Lead Optimization
5.4.4.1 Qsar (Quantitative Structure–Activity Relationship) Models
6 GLOBAL BIO SIMULATION TECHNOLOGY MARKET, BY PRODUCT
6.1 Introduction
6.2 Software
6.2.1 Toxicity Prediction Software
6.2.2 Molecular Modeling and Simulation Software
6.2.3 Trial Design Software
6.2.4 PK/PD Modeling and Simulation Software
6.2.5 Pbpk Modeling and Simulation Software
6.2.6 Other Software
6.3 Services
6.3.1 External/Contract Services
6.3.2 In-House Services
7 GLOBAL BIO SIMULATION TECHNOLOGY MARKET, BY END USER
7.1 Introduction
7.2 Regulatory Authorities
7.3 Academic and Government Research Institutes
7.4 Pharmaceutical and Biotechnology Companies
7.5 Contract Research Organizations
8 GLOBAL BIO SIMULATION TECHNOLOGY MARKET, BY GEOGRAPHY
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 COMPANY PROFILING
10.1 Certara USA, Inc.
10.2 Simulation Plus Inc.
10.3 Dassault Systèmes SA
10.4 Schrödinger Inc.
10.5 Advanced Chemistry Development, Inc.
10.6 Chemical Computing Group, Inc.
10.7 Entelos Holding Corporation
10.8 Genedata Ag
10.9 Physiomics PLC
10.10 Rhenovia Pharma Ltd.
10.11 Insilico biosciences
10.12 Archimedes
10.13 Insilico biotechnology
10.14 Accelrys
10.15 LeadScope
10.16 Compugen
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Regulatory Guidelines
3.7 Product Analysis
3.8 Application Analysis
3.9 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL BIO SIMULATION TECHNOLOGY MARKET, BY APPLICATION
5.1 Introduction
5.2 Application In Drug Development
5.2.1 Clinical Trials
5.2.1.1 Phase I Clinical Trial
5.2.1.2 Phase Ii Clinical Trial
5.2.1.3 Phase Iii Clinical Trial
5.2.2 Preclinical Testing
5.2.2.1 PK/PD
5.2.2.2 ADME/TOX
5.3 In Patient Validation
5.4 Application In Drug Discovery
5.4.1 Target Validation
5.4.1.1 Molecular Modeling
5.4.2 Target Identification
5.4.2.1 Protein Structure Prediction
5.4.3 Lead Identification/Discovery
5.4.3.1 De Novo Design
5.4.4 Lead Optimization
5.4.4.1 Qsar (Quantitative Structure–Activity Relationship) Models
6 GLOBAL BIO SIMULATION TECHNOLOGY MARKET, BY PRODUCT
6.1 Introduction
6.2 Software
6.2.1 Toxicity Prediction Software
6.2.2 Molecular Modeling and Simulation Software
6.2.3 Trial Design Software
6.2.4 PK/PD Modeling and Simulation Software
6.2.5 Pbpk Modeling and Simulation Software
6.2.6 Other Software
6.3 Services
6.3.1 External/Contract Services
6.3.2 In-House Services
7 GLOBAL BIO SIMULATION TECHNOLOGY MARKET, BY END USER
7.1 Introduction
7.2 Regulatory Authorities
7.3 Academic and Government Research Institutes
7.4 Pharmaceutical and Biotechnology Companies
7.5 Contract Research Organizations
8 GLOBAL BIO SIMULATION TECHNOLOGY MARKET, BY GEOGRAPHY
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt
9 KEY DEVELOPMENTS
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 COMPANY PROFILING
10.1 Certara USA, Inc.
10.2 Simulation Plus Inc.
10.3 Dassault Systèmes SA
10.4 Schrödinger Inc.
10.5 Advanced Chemistry Development, Inc.
10.6 Chemical Computing Group, Inc.
10.7 Entelos Holding Corporation
10.8 Genedata Ag
10.9 Physiomics PLC
10.10 Rhenovia Pharma Ltd.
10.11 Insilico biosciences
10.12 Archimedes
10.13 Insilico biotechnology
10.14 Accelrys
10.15 LeadScope
10.16 Compugen
LIST OF TABLES
Global Bio Simulation Technology Market Outlook, By Region (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Application (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Application In Drug Development (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Clinical Trials (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Preclinical Testing (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By In Patient Validation (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Application In Drug Discovery (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Target Validation (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Target Identification (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Lead Optimization (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Product (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Trial Design Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Other Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Services (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By External/Contract Services (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By In-House Services (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By End user (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Regulatory Authorities (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Contract Research Organizations (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Application (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Application In Drug Development (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Clinical Trials (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Preclinical Testing (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By In Patient Validation (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Application In Drug Discovery (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Target Validation (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Target Identification (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Lead Optimization (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Product (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Trial Design Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Other Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Services (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By External/Contract Services (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By In-House Services (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By End user (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Regulatory Authorities (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Contract Research Organizations (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Application (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Application In Drug Development (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Clinical Trials (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Preclinical Testing (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By In Patient Validation (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Application In Drug Discovery (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Target Validation (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Target Identification (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Lead Optimization (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Product (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Trial Design Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Other Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Services (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By External/Contract Services (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By In-House Services (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By End user (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Regulatory Authorities (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Contract Research Organizations (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Application (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Application In Drug Development (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Clinical Trials (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Preclinical Testing (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By In Patient Validation (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Application In Drug Discovery (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Target Validation (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Target Identification (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Lead Optimization (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Product (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Trial Design Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Other Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Services (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By External/Contract Services (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By In-House Services (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By End user (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Regulatory Authorities (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Contract Research Organizations (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Application (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Application In Drug Development (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Clinical Trials (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Preclinical Testing (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By In Patient Validation (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Application In Drug Discovery (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Target Validation (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Target Identification (201-2022) ($MN)
1Rest of the World Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Lead Optimization (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Product (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Trial Design Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Other Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Services (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By External/Contract Services (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By In-House Services (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By End user (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Regulatory Authorities (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Contract Research Organizations (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Region (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Application (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Application In Drug Development (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Clinical Trials (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Preclinical Testing (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By In Patient Validation (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Application In Drug Discovery (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Target Validation (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Target Identification (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Lead Optimization (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Product (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Trial Design Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Other Software (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Services (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By External/Contract Services (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By In-House Services (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By End user (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Regulatory Authorities (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (201-2022) ($MN)
Global Bio Simulation Technology Market Outlook, By Contract Research Organizations (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Application (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Application In Drug Development (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Clinical Trials (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Preclinical Testing (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By In Patient Validation (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Application In Drug Discovery (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Target Validation (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Target Identification (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Lead Optimization (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Product (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Trial Design Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Other Software (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Services (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By External/Contract Services (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By In-House Services (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By End user (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Regulatory Authorities (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (201-2022) ($MN)
North America Bio Simulation Technology Market Outlook, By Contract Research Organizations (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Application (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Application In Drug Development (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Clinical Trials (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Preclinical Testing (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By In Patient Validation (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Application In Drug Discovery (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Target Validation (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Target Identification (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Lead Optimization (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Product (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Trial Design Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Other Software (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Services (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By External/Contract Services (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By In-House Services (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By End user (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Regulatory Authorities (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (201-2022) ($MN)
Europe Bio Simulation Technology Market Outlook, By Contract Research Organizations (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Application (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Application In Drug Development (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Clinical Trials (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Preclinical Testing (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By In Patient Validation (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Application In Drug Discovery (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Target Validation (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Target Identification (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Lead Optimization (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Product (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Trial Design Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Other Software (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Services (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By External/Contract Services (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By In-House Services (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By End user (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Regulatory Authorities (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (201-2022) ($MN)
Asia pacific Bio Simulation Technology Market Outlook, By Contract Research Organizations (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Application (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Application In Drug Development (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Clinical Trials (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Preclinical Testing (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By In Patient Validation (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Application In Drug Discovery (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Target Validation (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Target Identification (201-2022) ($MN)
1Rest of the World Bio Simulation Technology Market Outlook, By Lead Identification/Discovery (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Lead Optimization (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Product (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Toxicity Prediction Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Molecular Modeling and Simulation Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Trial Design Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By PK/PD Modeling and Simulation Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Pbpk Modeling and Simulation Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Other Software (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Services (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By External/Contract Services (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By In-House Services (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By End user (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Regulatory Authorities (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Academic and Government Research Institutes (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Pharmaceutical and Biotechnology Companies (201-2022) ($MN)
Rest of the World Bio Simulation Technology Market Outlook, By Contract Research Organizations (201-2022) ($MN)
